• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性脑膜炎球菌败血症。肝素治疗的效果。

Experimental meningococcal septicemia. Effect of heparin therapy.

作者信息

Gaskins R A, Dalldorf F G

出版信息

Arch Pathol Lab Med. 1976 Jun;100(6):318-24.

PMID:946760
Abstract

The pathogenesis of experimental meningococcal septicemia and the efficacy of heparin sodium therapy were evaluated by inoculating rabbits intraperitoneally with type B meningococci in mucin. Half the rabbits died, and the respiratory distress and circulatory failure that occurred during the terminal phase of the disease were associated with diffuse pulmonary capillary and venular thrombosis and with renal glomerular fibrin deposition. Platelet and leukocyte counts and plasma fibrinogen levels decreased in all rabbits, and prothrombin and partial thromboplastin times were prolonged. Pretreatment with heparin sodium diminished intravascular fibrin deposition but failed to prevent the pulmonary microthrombi and did not either reduce the mortality or improve the survival time. We conclude that death in meningococcal septicemia is due to widespread thrombosis of the pulmonary microcirculation. The disease is complicated by diffuse intravascular coagulation, which can be controlled with heparin sodium but which is not immediately life-threatening.

摘要

通过给家兔腹腔注射含有B型脑膜炎球菌的粘蛋白来评估实验性脑膜炎球菌败血症的发病机制及肝素钠治疗的疗效。半数家兔死亡,疾病终末期出现的呼吸窘迫和循环衰竭与弥漫性肺毛细血管和小静脉血栓形成以及肾小球纤维蛋白沉积有关。所有家兔的血小板和白细胞计数及血浆纤维蛋白原水平均降低,凝血酶原时间和部分凝血活酶时间延长。肝素钠预处理可减少血管内纤维蛋白沉积,但未能预防肺微血栓形成,也未降低死亡率或延长生存时间。我们得出结论,脑膜炎球菌败血症的死亡是由于肺微循环广泛血栓形成所致。该疾病并发弥漫性血管内凝血,可用肝素钠控制,但并非立即危及生命。

相似文献

1
Experimental meningococcal septicemia. Effect of heparin therapy.实验性脑膜炎球菌败血症。肝素治疗的效果。
Arch Pathol Lab Med. 1976 Jun;100(6):318-24.
2
Fatal meningococcal septicemia.
Arch Pathol Lab Med. 1977 Jan;101(1):6-9.
3
Experimental meningococcal septicemia. Effect of aspirin therapy.
Arch Pathol Lab Med. 1978 Oct;102(10):515-7.
4
Heparin for infants and children with meningococcal septicemia. Results of a randomized therapeutic trial.肝素用于患有脑膜炎球菌败血症的婴幼儿。一项随机治疗试验的结果。
NIPH Ann. 1983 Jun;6(1):43-7.
5
Activation of the coagulation cascade in patients with leptospirosis.钩端螺旋体病患者凝血级联反应的激活。
Clin Infect Dis. 2008 Jan 15;46(2):254-60. doi: 10.1086/524664.
6
[Coagulation tests in septic surgical patients].[脓毒症外科患者的凝血试验]
Acta Med Croatica. 2004;58(5):389-94.
7
Early heparin therapy in 60 children with acute meningococcemia. Relationship between clinical manifestations and coagulation abnormalities.60例急性脑膜炎球菌血症患儿的早期肝素治疗。临床表现与凝血异常之间的关系。
Acta Chir Belg. 1973 Jul;72(4):288-97.
8
Novel recombinant fibrinogenase of Agkistrodon acutus venom protects against LPS-induced DIC.尖吻蝮蛇毒新型重组纤维蛋白原酶可预防脂多糖诱导的弥散性血管内凝血。
Thromb Res. 2009 Apr;123(6):919-24. doi: 10.1016/j.thromres.2008.10.017. Epub 2008 Dec 13.
9
[Therapy with heparin in meningococcic sepsis].[肝素治疗脑膜炎球菌败血症]
Minerva Pediatr. 1969 Mar 10;21(10):394-401.
10
Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.蛋白酶抑制剂、纤溶酶原抗激活剂、肝素和乙酰水杨酸对凝血酶诱导的实验性弥散性血管内凝血的比较作用。
Thromb Diath Haemorrh. 1974 Sep 30;32(1):171-88.

引用本文的文献

1
Heparin protects against septic mortality via apoE-antagonism.肝素通过拮抗载脂蛋白 E 发挥抗脓毒症作用,降低死亡率。
Am J Surg. 2011 Sep;202(3):325-35. doi: 10.1016/j.amjsurg.2010.10.017. Epub 2011 Jul 8.
2
The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies.肝素给药对脓毒症动物模型的影响:大肠杆菌攻毒小鼠的前瞻性研究和已发表研究的系统评价和荟萃回归分析。
Crit Care Med. 2011 May;39(5):1104-12. doi: 10.1097/CCM.0b013e31820eb718.
3
Update on meningococcal disease with emphasis on pathogenesis and clinical management.
脑膜炎球菌病最新进展,重点关注发病机制与临床管理。
Clin Microbiol Rev. 2000 Jan;13(1):144-66, table of contents. doi: 10.1128/CMR.13.1.144.
4
Current drug treatment strategies for disseminated intravascular coagulation.弥散性血管内凝血的当前药物治疗策略
Drugs. 1998 Jun;55(6):767-77. doi: 10.2165/00003495-199855060-00004.
5
Pathology in rabbits treated with leukocyte-degraded meningococci in combination with meningococcal endotoxin.用白细胞降解的脑膜炎双球菌与脑膜炎双球菌内毒素联合处理的兔子的病理学。
Infect Immun. 1977 Apr;16(1):271-9. doi: 10.1128/iai.16.1.271-279.1977.